バイオシミラーモノクローナル抗体の世界市場レポート2020

• 英文タイトル：Global Biosimilar Monoclonal Antibodies Sales Market Report 2020

• レポートコード：MRC2102QY1933 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYリサーチ社の本調査レポートでは、世界のバイオシミラーモノクローナル抗体市場について種類別（インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他）、用途別（腫瘍学、自己免疫疾患、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・バイオシミラーモノクローナル抗体市場の概要 ・世界の主要地域別バイオシミラーモノクローナル抗体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のバイオシミラーモノクローナル抗体市場規模2015-2026：種類別（インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他） ・世界のバイオシミラーモノクローナル抗体市場規模2015-2026：用途別（腫瘍学、自己免疫疾患、その他） ・バイオシミラーモノクローナル抗体の米国市場規模2015-2020 ・バイオシミラーモノクローナル抗体のヨーロッパ市場規模2015-2020 ・バイオシミラーモノクローナル抗体の中国市場規模2015-2020 ・バイオシミラーモノクローナル抗体の日本市場規模2015-2020 ・バイオシミラーモノクローナル抗体の東南アジア市場規模2015-2020 ・バイオシミラーモノクローナル抗体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・バイオシミラーモノクローナル抗体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・バイオシミラーモノクローナル抗体の市場動向・機会・課題 ・調査の結論

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.
The classification of Biosimilar Monoclonal Antibodies includes Infliximab, Rituximab, Trastuzumab, Adalimumab and Other, and the sales proportion of Infliximab in 2017 is about 36.5%.

Market Analysis and Insights: Global Biosimilar Monoclonal Antibodies Market
The global Biosimilar Monoclonal Antibodies market size is projected to reach US$ 25770 million by 2026, from US$ 5942.7 million in 2020, at a CAGR of 27.7% during 2021-2026.

Global Biosimilar Monoclonal Antibodies Scope and Market Size
The global Biosimilar Monoclonal Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Biosimilar Monoclonal Antibodies market is segmented into
Infliximab
Rituximab
Trastuzumab
Adalimumab
Other

Segment by Application, the Biosimilar Monoclonal Antibodies market is segmented into
Oncology
Autoimmune Disease
Other

The Biosimilar Monoclonal Antibodies market is analysed and market size information is provided by regions (countries). Segment by Application, the Biosimilar Monoclonal Antibodies market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Biosimilar Monoclonal Antibodies Market Share Analysis
Biosimilar Monoclonal Antibodies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilar Monoclonal Antibodies business, the date to enter into the Biosimilar Monoclonal Antibodies market, Biosimilar Monoclonal Antibodies product introduction, recent developments, etc.

The major vendors covered:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals

レポート目次

---

1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Biosimilar Monoclonal Antibodies Product Scope
1.2 Biosimilar Monoclonal Antibodies Segment by Type
1.2.1 Global Biosimilar Monoclonal Antibodies Sales by Type (2020-2026)
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Biosimilar Monoclonal Antibodies Segment by Application
1.3.1 Global Biosimilar Monoclonal Antibodies Sales Comparison by Application (2020-2026)
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Biosimilar Monoclonal Antibodies Market Estimates and Forecasts (2015-2026)
1.4.1 Global Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2026)
1.4.2 Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2015-2026)
1.4.3 Global Biosimilar Monoclonal Antibodies Price Trends (2015-2026)

2 Biosimilar Monoclonal Antibodies Estimate and Forecast by Region
2.1 Global Biosimilar Monoclonal Antibodies Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Biosimilar Monoclonal Antibodies Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2020)
2.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
2.3 Global Biosimilar Monoclonal Antibodies Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Biosimilar Monoclonal Antibodies Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Biosimilar Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.2 Europe Biosimilar Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.3 China Biosimilar Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.4 Japan Biosimilar Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Biosimilar Monoclonal Antibodies Estimates and Projections (2015-2026)
2.4.6 India Biosimilar Monoclonal Antibodies Estimates and Projections (2015-2026)
3 Global Biosimilar Monoclonal Antibodies Competition Landscape by Players
3.1 Global Top Biosimilar Monoclonal Antibodies Players by Sales (2015-2020)
3.2 Global Top Biosimilar Monoclonal Antibodies Players by Revenue (2015-2020)
3.3 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2019)
3.4 Global Biosimilar Monoclonal Antibodies Average Price by Company (2015-2020)
3.5 Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Biosimilar Monoclonal Antibodies Players (Opinion Leaders)
4 Global Biosimilar Monoclonal Antibodies Market Size by Type
4.1 Global Biosimilar Monoclonal Antibodies Historic Market Review by Type (2015-2020)
4.1.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
4.1.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2015-2020)
4.1.3 Global Biosimilar Monoclonal Antibodies Price by Type (2015-2020)
4.2 Global Biosimilar Monoclonal Antibodies Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2021-2026)
4.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2021-2026)
4.2.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2021-2026)
5 Global Biosimilar Monoclonal Antibodies Market Size by Application
5.1 Global Biosimilar Monoclonal Antibodies Historic Market Review by Application (2015-2020)
5.1.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
5.1.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
5.1.3 Global Biosimilar Monoclonal Antibodies Price by Application (2015-2020)
5.2 Global Biosimilar Monoclonal Antibodies Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2021-2026)
5.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application (2021-2026)
5.2.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Application (2021-2026)

6 United States Biosimilar Monoclonal Antibodies Market Facts & Figures
6.1 United States Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
6.2 United States Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
6.3 United States Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

7 Europe Biosimilar Monoclonal Antibodies Market Facts & Figures
7.1 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
7.2 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
7.3 Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

8 China Biosimilar Monoclonal Antibodies Market Facts & Figures
8.1 China Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
8.2 China Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
8.3 China Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

9 Japan Biosimilar Monoclonal Antibodies Market Facts & Figures
9.1 Japan Biosimilar Monoclonal Antibodies Sales Market Share by Company (3015-3030)
9.2 Japan Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
9.3 Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

10 Southeast Asia Biosimilar Monoclonal Antibodies Market Facts & Figures
10.1 Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

11 India Biosimilar Monoclonal Antibodies Market Facts & Figures
11.1 India Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
11.2 India Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
11.3 India Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Biosimilar Monoclonal Antibodies Business
12.1 Celltrion
12.1.1 Celltrion Corporation Information
12.1.2 Celltrion Business Overview
12.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Celltrion Biosimilar Monoclonal Antibodies Products Offered
12.1.5 Celltrion Recent Development
12.2 Pfizer (Hospira)
12.2.1 Pfizer (Hospira) Corporation Information
12.2.2 Pfizer (Hospira) Business Overview
12.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Products Offered
12.2.5 Pfizer (Hospira) Recent Development
12.3 3SBIO
12.3.1 3SBIO Corporation Information
12.3.2 3SBIO Business Overview
12.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.3.4 3SBIO Biosimilar Monoclonal Antibodies Products Offered
12.3.5 3SBIO Recent Development
12.4 Novartis (Sandoz)
12.4.1 Novartis (Sandoz) Corporation Information
12.4.2 Novartis (Sandoz) Business Overview
12.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Products Offered
12.4.5 Novartis (Sandoz) Recent Development
12.5 Dr Reddy’s
12.5.1 Dr Reddy’s Corporation Information
12.5.2 Dr Reddy’s Business Overview
12.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Products Offered
12.5.5 Dr Reddy’s Recent Development
12.6 Celgen Biopharma
12.6.1 Celgen Biopharma Corporation Information
12.6.2 Celgen Biopharma Business Overview
12.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Products Offered
12.6.5 Celgen Biopharma Recent Development
12.7 Cadila Healthcare
12.7.1 Cadila Healthcare Corporation Information
12.7.2 Cadila Healthcare Business Overview
12.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Products Offered
12.7.5 Cadila Healthcare Recent Development
12.8 Hisun Pharma
12.8.1 Hisun Pharma Corporation Information
12.8.2 Hisun Pharma Business Overview
12.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Products Offered
12.8.5 Hisun Pharma Recent Development
12.9 Torrent Pharmaceuticals
12.9.1 Torrent Pharmaceuticals Corporation Information
12.9.2 Torrent Pharmaceuticals Business Overview
12.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Products Offered
12.9.5 Torrent Pharmaceuticals Recent Development

13 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
13.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
13.4 Biosimilar Monoclonal Antibodies Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biosimilar Monoclonal Antibodies Distributors List
14.3 Biosimilar Monoclonal Antibodies Customers

15 Market Dynamics
15.1 Biosimilar Monoclonal Antibodies Market Trends
15.2 Biosimilar Monoclonal Antibodies Opportunities and Drivers
15.3 Biosimilar Monoclonal Antibodies Market Challenges
15.4 Biosimilar Monoclonal Antibodies Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Biosimilar Monoclonal Antibodies Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Biosimilar Monoclonal Antibodies Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Region (2015-2020)
Table 5. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Table 6. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Biosimilar Monoclonal Antibodies Revenue Share by Region (2015-2020)
Table 8. Global Biosimilar Monoclonal Antibodies Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Biosimilar Monoclonal Antibodies Revenue Share Forecast by Region (2021-2026)
Table 12. Global Biosimilar Monoclonal Antibodies (K Units) of Key Companies (2015-2020)
Table 13. Global Biosimilar Monoclonal Antibodies Sales Share by Company (2015-2020)
Table 14. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Biosimilar Monoclonal Antibodies Revenue Share by Company (2015-2020)
Table 16. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2019)
Table 17. Global Biosimilar Monoclonal Antibodies Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Biosimilar Monoclonal Antibodies Manufacturing Sites and Area Served
Table 19. Manufacturers Biosimilar Monoclonal Antibodies Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Biosimilar Monoclonal Antibodies Players
Table 22. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020)
Table 23. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2015-2020)
Table 24. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Biosimilar Monoclonal Antibodies Price (K Units) by Type (2015-2020)
Table 26. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2021-2026)
Table 27. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2021-2026)
Table 29. Global Biosimilar Monoclonal Antibodies Price (K Units) by Type (2021-2026)
Table 30. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2015-2020)
Table 31. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2015-2020)
Table 32. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Biosimilar Monoclonal Antibodies Price (K Units) by Application (2015-2020)
Table 34. Global Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2021-2026)
Table 35. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2021-2026)
Table 36. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2021-2026)
Table 38. Global Biosimilar Monoclonal Antibodies Price (K Units) by Application (2021-2026)
Table 39. United States Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2015-2020)
Table 40. United States Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 41. United States Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020)
Table 42. United States Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 43. United States Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2015-2020)
Table 44. United States Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 45. Europe Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2015-2020)
Table 46. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 47. Europe Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020)
Table 48. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 49. Europe Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2015-2020)
Table 50. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 51. China Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2015-2020)
Table 52. China Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 53. China Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020)
Table 54. China Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 55. China Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2015-2020)
Table 56. China Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 57. Japan Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2015-2020)
Table 58. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 59. Japan Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020)
Table 60. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 61. Japan Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2015-2020)
Table 62. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 69. India Biosimilar Monoclonal Antibodies Sales (K Units) by Company (2015-2020)
Table 70. India Biosimilar Monoclonal Antibodies Sales Market Share by Company (2015-2020)
Table 71. India Biosimilar Monoclonal Antibodies Sales (K Units) by Type (2015-2020)
Table 72. India Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 73. India Biosimilar Monoclonal Antibodies Sales (K Units) by Application (2015-2020)
Table 74. India Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 75. Celltrion Corporation Information
Table 76. Celltrion Description and Business Overview
Table 77. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Celltrion Biosimilar Monoclonal Antibodies Product
Table 79. Celltrion Recent Development
Table 80. Pfizer (Hospira) Corporation Information
Table 81. Pfizer (Hospira) Description and Business Overview
Table 82. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product
Table 84. Pfizer (Hospira) Recent Development
Table 85. 3SBIO Corporation Information
Table 86. 3SBIO Description and Business Overview
Table 87. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. 3SBIO Biosimilar Monoclonal Antibodies Product
Table 89. 3SBIO Recent Development
Table 90. Novartis (Sandoz) Corporation Information
Table 91. Novartis (Sandoz) Description and Business Overview
Table 92. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product
Table 94. Novartis (Sandoz) Recent Development
Table 95. Dr Reddy’s Corporation Information
Table 96. Dr Reddy’s Description and Business Overview
Table 97. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Dr Reddy’s Biosimilar Monoclonal Antibodies Product
Table 99. Dr Reddy’s Recent Development
Table 100. Celgen Biopharma Corporation Information
Table 101. Celgen Biopharma Description and Business Overview
Table 102. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Celgen Biopharma Biosimilar Monoclonal Antibodies Product
Table 104. Celgen Biopharma Recent Development
Table 105. Cadila Healthcare Corporation Information
Table 106. Cadila Healthcare Description and Business Overview
Table 107. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Cadila Healthcare Biosimilar Monoclonal Antibodies Product
Table 109. Cadila Healthcare Recent Development
Table 110. Hisun Pharma Corporation Information
Table 111. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Hisun Pharma Description and Business Overview
Table 113. Hisun Pharma Biosimilar Monoclonal Antibodies Product
Table 114. Hisun Pharma Recent Development
Table 115. Torrent Pharmaceuticals Corporation Information
Table 116. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Torrent Pharmaceuticals Description and Business Overview
Table 118. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product
Table 119. Torrent Pharmaceuticals Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Biosimilar Monoclonal Antibodies Distributors List
Table 123. Biosimilar Monoclonal Antibodies Customers List
Table 124. Biosimilar Monoclonal Antibodies Market Key Trends
Table 125. Biosimilar Monoclonal Antibodies Key Opportunities and Drivers
Table 126. Biosimilar Monoclonal Antibodies Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Monoclonal Antibodies Product Picture
Figure 2. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Biosimilar Monoclonal Antibodies Market Share by Application in 2020 & 2026
Figure 6. Oncology Examples
Figure 7. Autoimmune Disease Examples
Figure 8. Other Examples
Figure 9. Global Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Biosimilar Monoclonal Antibodies Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Biosimilar Monoclonal Antibodies Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Biosimilar Monoclonal Antibodies Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Biosimilar Monoclonal Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Biosimilar Monoclonal Antibodies Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Biosimilar Monoclonal Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Biosimilar Monoclonal Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Biosimilar Monoclonal Antibodies Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Biosimilar Monoclonal Antibodies Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Biosimilar Monoclonal Antibodies Players Market Share by Revenue in Biosimilar Monoclonal Antibodies 2015 & 2019
Figure 27. Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2015-2020)
Figure 29. Global Biosimilar Monoclonal Antibodies Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2015-2020)
Figure 31. Global Biosimilar Monoclonal Antibodies Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 33. United States Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 34. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 35. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 36. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 37. China Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 38. China Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 39. China Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 40. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 41. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 42. Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 43. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 44. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 45. Southeast Asia Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 46. India Biosimilar Monoclonal Antibodies Sales Market Share by Company in 2019
Figure 47. India Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 48. India Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Figure 51. Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure 52. Biosimilar Monoclonal Antibodies Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

---